MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Clinical and imaging features of idiopathic cerebellar ataxia with anti-cerebellar antibodies

    A. Takekoshi, A. Kimura, N. Yoshikura, T. Shimohata (Gifu, Japan)

    Objective: The current study sought to determine whether autoimmunity can account for some cases of IDCA. Background: Idiopathic cerebellar ataxia (IDCA) is the clinical-based term…
  • MDS Virtual Congress 2021

    Hemichorea as an initial symptom of antibodies against contactin- associated protein-like 2 (CASPR2) encephalitis

    A. Ventura, G. Lopez, MA. Piedrabuena, E. Seminara, E. Garino, D. Ballesteros (Buenos Aires, Argentina)

    Objective: Describe a case of hemichorea as the initial symptom of CASPR2 encephalitis. Background: The clinical spectrum of syndromes associated with CASPR2 is extensive and…
  • MDS Virtual Congress 2021

    Evaluation of the QTc prolongation risk of deutetrabenazine

    F. Schneider, B. Darpo, M. Gutierrez, M. Gordon, L. Rabinovich-Guilatt (Ulm, Germany)

    Objective: To assess QTc prolongation risk of deutetrabenazine and its active metabolites by conducting exposure-QTc interval modeling, and to predict QTc prolongation in both CYP2D6…
  • MDS Virtual Congress 2021

    Botulinum Toxin Injections For Movement Disorders During the COVID-19 Pandemic: A Single-Center Experience

    B. Dorfman, M. Velickovic, W. Tse (New York, USA)

    Objective: To report on patterns of patients presenting to our center for botulinum toxin injections during the height of the COVID-19 pandemic in New York…
  • MDS Virtual Congress 2021

    A National Data-Linkage Study of Incidence and Prevalence of Primary Dystonia

    G. Bailey, A. Rawlings, W. Pickrell, K. Peall (Cardiff, United Kingdom)

    Objective: To determine the nationwide prevalence and incidence rates of primary dystonia in Wales. Background: The true prevalence and incidence of dystonia remains largely unknown…
  • MDS Virtual Congress 2021

    DNMSQuest: a simple tool for identifying mood disorders in cervical dystonia?

    S. Rafee, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To compare DNMSQuest scores with validated measures of mood disorder in cervical dystonia patients attending a hospital botulinum toxin clinic. We wished to determine…
  • MDS Virtual Congress 2021

    Sensory Tricks Modulate Corticocortical and Corticomuscular Connectivity in Cervical Dystonia

    S. Cho, S. Lee, H. Shin, M. Hallett (Bethesda, USA)

    Objective: To examine mechanisms underlying sensory tricks in cervical dystonia (CD) by examining interactions between cortical areas and between cortical areas and relevant muscles. Background:…
  • MDS Virtual Congress 2021

    Movement Disorder Fellowships: Assessment and Recruitment Strategies to Meet Clinical Needs

    M. Rashid, A. Zafar, J. Owens, G. Patino, M. Robbins, S. Sandrone, H. Sarva (Ottawa Hills, USA)

    Objective: 1. Identify factors leading to lower number of residents interested in movement disorders fellowship. 2. Propose strategies to increase recruitment. Background: The prevalence of…
  • MDS Virtual Congress 2021

    Longitudinal healthcare utilization and costs in Parkinson disease : from pre-diagnosis to 9 years

    S. Neo, E. Soh, A. Wong, W. Li, HL. Ng, KY. Tay, WL. Au, L. Tan (Singapore, Singapore)

    Objective: The aim of this study was to characterize attributable healthcare utilization and costs in Parkinson disease (PD) in newly diagnosed PD patients managed by…
  • MDS Virtual Congress 2021

    Neuropsychiatric evaluation in patients with functionel movements disorders

    M. Balal, S. çakmak, M. Demirkiran (Adana, Turkey)

    Objective: The aim of this study is to investigate the neuropsychiatric evaluations in patients with functional movement disorders. Background: Functional movement disorders include a group…
  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley